Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag EU lawmakers approved new drug rules on Dec. 11, 2025, boosting innovation and access with extended protections, subscription pricing, and stronger generics and shortage safeguards.

flag EU lawmakers have agreed on a major overhaul of pharmaceutical regulations, setting new rules to balance innovation and patient access. flag Drugs will get up to 11 years of combined data and market protection, with extensions for unmet medical needs or rare diseases. flag A subscription model decouples revenue from sales, and countries can demand supply with penalties for non-compliance. flag The reform includes faster EMA processing, digital patient leaflets, and mandatory shortage prevention plans. flag It also introduces transferable vouchers for priority antimicrobials and strengthens generics access through clearer patent exemptions. flag The deal, finalized December 11, 2025, aims to boost Europe’s drug competitiveness and health security.

6 Articles